Celebrex, Bextra Claims Withstand Judge's Scrutiny
The judge overseeing the massive products liability litigation over anti-inflammatory pain medications Celebrex and Bextra has rejected Pfizer Inc.'s request to have several of the claims at the heart of the...To view the full article, register now.
Already a subscriber? Click here to view full article